Recurrent intestinal metaplasia in the gastroesophageal junction after endoscopic eradication of Barrett’s: Is ignorance bliss?

Endoscopic eradication therapy for Barrett’s esophagus (BE) with early esophageal adenocarcinoma (EAC), high-grade dysplasia (HGD), or low-grade dysplasia (LGD) has become the standard of care to cure neoplasia and minimize the risk of recurrence. Different modalities for endoscopic eradication therapy have been described. Of those, endoscopic resection of any visible lesions, followed by radiofrequency ablation (RFA) of the remaining BE, is...